Roche Suffers Cancer Treatment Setback
Basel-based Roche said a phase III study of onartuzumab, a drug developed to control certain types of non-small cell lung cancer, lacked "clinically meaningful efficacy." The study was designed to measure whether onartuzumab, used with the oral drug …
Read more on Wall Street Journal

Brentiximab Vedotin removes cancer patient's 70 lethal tumours in 12 weeks
Scans of Mr Brook's body before and after treatment. The left shows him riddled with 60-70 tumours from Non-Hodgkin's Lymphoma. The right scan is 12 weeks after he became the first person outside the U.S. to have a pioneering cancer drug. The black …
Read more on Daily Mail